Qynapse receives FDA clearance for QyScore®, a novel imaging software for central nervous system diseases

QyScore® allows automated quantification of a broad portfolio of Magnetic Resonance Imaging markers that are key to support early diagnosis and clinical monitoring of neurodegenerative disorders

Qynapse exhibits at the 2019 Alzheimer’s Association International Conference (AAIC) in Los Angeles, CA

From July 14 – 18th, Qynapse will be part of the 2019 Alzheimer’s Association International Conference® (AAIC®) held in Los Angeles, California

Qynapse releases new validation results of QyScore performance

QyScore®, the software by Qynapse that provides automated volumetric measurements of brain structures, takes a big step forward with the validation of performance for one of its major functionalities

Qynapse attended the 14th AD/PD International Conference

Qynapse took part in the 2019 International Conference on Alzheimer’s & Parkinson’s Disease (AD/PDTM) in Lisbon, Portugal from March 26 – 31st

Qynapse partners with AG Mednet

Qynapse is pleased to announce the signing of a partnership agreement with AG Mednet, the leading provider of medical trials data management services, for the use of its Judi imaging adjudication system

Qynapse featured on the French television network “France 3”

On September 20th 2018, Qynapse was featured on the evening news program of the French network France 3 in a report dedicated to Alzheimer’s disease diagnosis